The applicant's goal is to further understand transcriptional responses of cells during inflammation. Cells have the capacity to respond to injury during inflammation by elaboration of heat shock genes. The subsequent accumulation of heat shock proteins (hsp) serve multiple functions that confers cellular resistance to unfavorable environments. These functions include protection of newly synthesized polypeptides, disaggregation of damaged proteins, mediation of protein traffic, and provision of molecular brakes for transcription factors. Thus, understanding how heat shock genes are regulated has important implications for clinical interventions designed to enhance cellular repair and to protect cells from inflammation. Activation of the heat shock transcription factor, HSF1, is essential for maximal transcriptional activity. Heat itself stimulates an unknown signaling cascade that leads to HSF1 unfolding, multimerization, and phosphorylation. The thermal-induced response results in a 5-100 fold increase in transcription of the heat shock genes. Because heat causes pleitrophic effects, analysis of the signals mediating activation of HSF1 have been difficult to assess. However, the applicant has found a mediator of inflammation, arachidonic acid, to be a potent inducer of HSF1, thus offering a new approach towards understanding the signals that trigger HSF1 leading to increased heat shock gene expression.
The specific aims are i) to identify the arachidonate-sensitive domain of HSF1 responsible for multimerization and ii) to isolate and characterize an arachidonate-inducible kinase. Information obtained from this program will increase our understanding of how arachidonate modulates gene expression through induction of a specific transcription factor. It also provides the basis for analyzing a broader question of how arachidonate mediates induction and possibly repression of inflammatory genes other than the heat shock genes. By understanding how arachidonate mediates molecular switches, new clinical approaches may be derived to alter gene expression so as to enhance cytoprotection during inflammation.

Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1996
Total Cost
Indirect Cost
Poornima, I G; Shields, K; Kuller, L H et al. (2018) Associations of osteoprotegerin with coronary artery calcification among women with systemic lupus erythematosus and healthy controls. Lupus :961203317751060
Demirci, F Yesim; Wang, Xingbin; Morris, David L et al. (2017) Multiple signals at the extended 8p23 locus are associated with susceptibility to systemic lupus erythematosus. J Med Genet 54:381-389
Demirci, F Yesim; Wang, Xingbin; Kelly, Jennifer A et al. (2016) Identification of a New Susceptibility Locus for Systemic Lupus Erythematosus on Chromosome 12 in Individuals of European Ancestry. Arthritis Rheumatol 68:174-83
Zhao, Jian; Giles, Brendan M; Taylor, Rhonda L et al. (2016) Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA. Ann Rheum Dis 75:242-52
Kottyan, Leah C; Zoller, Erin E; Bene, Jessica et al. (2015) The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Hum Mol Genet 24:582-96
Parker, Ben; Urowitz, Murray B; Gladman, Dafna D et al. (2015) Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort. Ann Rheum Dis 74:1530-6
Martins, M; Williams, A H; Comeau, M et al. (2015) Genetic association of CD247 (CD3?) with SLE in a large-scale multiethnic study. Genes Immun 16:142-50
Bernatsky, Sasha; Ramsey-Goldman, Rosalind; Joseph, Lawrence et al. (2014) Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Ann Rheum Dis 73:138-42
Lertratanakul, Apinya; Wu, Peggy; Dyer, Alan R et al. (2014) Risk factors in the progression of subclinical atherosclerosis in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 66:1177-85
Kaiser, Rachel; Tang, Ling Fung; Taylor, Kimberly E et al. (2014) A polymorphism in TLR2 is associated with arterial thrombosis in a multiethnic population of patients with systemic lupus erythematosus. Arthritis Rheumatol 66:1882-7

Showing the most recent 10 out of 248 publications